Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Yakov Muzalevsky"'
Autor:
Larisa Shelikhova, Arina Rakhteenko, Olga Molostova, Elena Kurnikova, V. Ukrainskaya, Yakov Muzalevsky, Dmitry Pershin, Alexander Popov, Elena Kulakovskaya, Dina Baidildina, Alexey Stepanov, Elena Osipova, Galina Novichkova, Alexey Maschan, Michael Maschan
Publikováno v:
Blood. 140:4600-4601
Autor:
Maria Ilushina, Elvira Sultanova, Larisa Shelikhova, Svetlana Glushkova, Alexey Kazachenok, Elena Kurnikova, Kristina S. Antonova, Ruslan Nikolaev, Anna Bogoyavlenskaya, Galina Novichkova, Michael Maschan, Dmitriy Balashov, Elena Osipova, Tatiana Salimova, Julia Skvortsova, Yakov Muzalevsky, Alexey Maschan, Daria Shasheleva, Dmitry Pershin, Svetlana Radygina
Publikováno v:
Blood. 138:558-558
Introduction HSCT from matched family donors results in most favorable outcomes among children with severe aplastic anemia (SAA). Despite overall success, morbidity, associated with acute and chronic graft-versus-host disease (GVHD) is not completely
Autor:
Larisa Shelikhova, Olga Molostova, Arina Rakhteenko, Rimma Khismatullina, Julia Abugova, Elena Kurnikova, Yakov Muzalevsky, Alexey Kazachenok, Dmitry Pershin, Maria Fadeeva, Alexander M Popov, Olga Illarionova, Natalia Miakova, Dmitry Litvinov, Galina Novichkova, Alexey Maschan, Michael Maschan
Publikováno v:
Blood. 138:1736-1736
Introduction Autologous chimeric antigen receptor (CAR) T cells induce high rate of deep remissions among children with relapsed/refractory B-precursor acute lymphoblastic leukemia (R/R B-ALL). In a significant proportion of patients true cure is ach
Autor:
Olga Molostova, Larisa Shelikhova, Yakov Muzalevsky, Alexey Kazachenok, Rimma Khismatullina, Julia Abugova, Elena Kurnikova, Pavel Trakhtman, Dmitry Pershin, Viktoria Zubachenko, Maria Fadeeva, Alexander M Popov, Olga Illarionova, Natalia Miakova, Dmitry Litvinov, Galina Novichkova, Alexey Maschan, Michael Maschan
Publikováno v:
Blood. 138:1737-1737
Introduction CD19 CAR-T is a highly effective therapy among children with relapsed/refractory B-ALL. The optimal approach to delivery of this therapy and the best post-remission strategy remain to be established. We have tested in a prospective acade
Autor:
Irina Shipitsina, Daria Kobyzeva, Maria Ilushina, Alexander Popov, Julia Abugova, Elena Kurnikova, Ekaterina Mikhailova, Yulia Olshanskaya, Larisa Shelikhova, Maria Fadeeva, Michael Maschan, Dmitriy Balashov, Alexey Maschan, Anna Bogoyavlenskaya, Zhanna Shekhovtsova, Alexey Nechesnyuk, Daria Shasheleva, Rimma Khismatullina, Alexey Kazachenok, Sergey Blagov, Natalia Miakova, Dmitriy Pershin, Yakov Muzalevsky, Galina Novichkova, Dmitry Litvinov
Publikováno v:
Blood. 134:4618-4618
Introduction Allogeneic hematopoietic stem cell transplantation (HSCT) is indicated for patients with relapsed or refractory acute lymphoblastic leukemia. Patients with persistence of minimal residual disease (MRD) before HCT are at increased risk of
Autor:
Alexander Popov, Alexey Kazachenok, Dmitriy Pershin, Alexey Maschan, Daria Shasheleva, Rimma Khismatullina, Larisa Shelikhova, Elena Kurnikova, Evgeny V. Gluhanyuk, Yakov Muzalevsky, Galina Novichkova, Svetlana Kashpor, Irina Kalinina, Dmitriy Balashov, Michael Maschan
Publikováno v:
Blood. 134:150-150
Introduction The outcome HSCT in a cohort of children with chemorefractory acute leukemia (AL) is poor. The incidence of relapse exceeds 50% and survival varies from 10 to 40%. Additional attempts at remission induction with various combinations of c
Autor:
Elena Kurnikova, Irina Shipitsina, Maria Fadeeva, Anna Bogoyavlenskaya, Svetlana Kozlovskaya, Dmitriy Pershin, Michael Maschan, Dmitriy Balashov, Maria Ilushina, Alexey Nechesnyuk, Elena Gutovskaya, Yakov Muzalevsky, Yulia Olshanskaya, Dmitry Litvinov, Zhanna Shekhovtsova, Alexey Maschan, Alexey Kazachenok, Sergey Blagov, Galina Novichkova, Rimma Khismatullina, Natalia Miakova, Irina Kalinina, Daria Shasheleva, Larisa Shelikhova
Publikováno v:
Blood. 132:481-481
Introduction Relapse, graft-versus-host disease (GvHD) and associated non-relapse mortality are the main obstacles to successful hematopoietic stem cell transplantation in children with leukemia. αβ T cell depletion was developed to prevent GvHD an
Autor:
Maria Alyabeva, Larisa Shelikhova, Daria Shasheleva, Rimma Khismatullina, Svetlana Radygina, Anna Bogoyavlenskaya, Sergey Blagov, Olga Molostova, Svetlana Kozlovskaya, Irina Kalinina, Elena Kurnikova, Yakov Muzalevsky, Dmitriy Pershin, Alexander Popov, Olga Illarionova, Yulia Olshanskaya, Natalia Miakova, Dmitry Litvinov, Galina Novichkova, Alexey A. Maschan, Michael Maschan
Publikováno v:
Blood. 132:2084-2084
Introduction The outcome hematopoietic stem cell transplantation (HSCT) in a cohort of children with chemorefractory leukemia is poor. The incidence of relapse exceeds 50% and survival varies from 10 to 40%. Additional attempts at remission induction
Autor:
Boro Dropulic, Dmitry Litvinov, Yakov Muzalevsky, Galina Novichkova, Regina Alex, Alexander Karachunskiy, Mike Essl, Alexander Popov, Olga Molostova, Larisa Shelikhova, Rimas Orentas, Michael Maschan, Dmitriy Pershin, Dina Shneider, Elena Kurnikova, Alexey Maschan, Alexey Kazachenok, Natalia Miakova
Publikováno v:
Blood. 132:5202-5202
Introduction CD19 CAR-T cell products were recently approved as therapy for advanced B-cell lineage malignancies. The predominant manufacturing model for this type of therapy is a centralized industrial-type production process. An attractive model of
Autor:
Michael Maschan, Elena Boyakova, Larisa Shelikhova, Yakov Muzalevsky, Elena Gutovskaya, Irina Shipitsina, Daria Shasheleva, Maria Ilushina, Anna Livshits, Alexei Kazachenok, Julia Skvortsova, Zhanna Shekhovtsova, Alexei Maschan, Rimma Khismatullina, Elana Kurnikova, Dmitriy Balashov
Publikováno v:
Biology of Blood and Marrow Transplantation. 22(3)